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A Simple and Rapid LC-MS/MS Method for the Determination of BMCL26 a
Novel Anti-Parasitic Agent in Rat Plasma
Ramakrishna R Voggu, Xiang Zhou, Bin Su and Baochuan Guo*
Department of Chemistry, Cleveland State University, USA

Abstract
BMCL26 is a potential drug derived from nimesulide, which has exhibited the substantial anti-parasitic activity in
various cell lines. To conduct various pharmacological and toxicological properties of this drug, we developed and
validated a rapid LC-MS/MS method for its quantification in accordance with the FDA guidelines. Protein precipitation
with 0.1% formic acid in acetonitrile was used to extract the analytes along with the internal standard (JCC76) from
rat plasma. It was found that the calibration curve of the method had an excellent linearity (r2 ≥ 0.9993) for the analyte
concentration ranging from 0.5 to 100 ng/mL with acceptable inter- and intra-assay, precision, accuracy and stability.
The matrix effect and extraction recovery were in the range of 101.30-110.10% and 90.16- 105.00%, respectively.
This LC-MS/MS method is simple and rapid and can be used in the future pharmaceutical studies of BMCL26.

Keywords:

Protein

T. brucei [10]. Webovertz’s group successfully developed several drug
candidates that show promising anti-parasite activity and selectivity in
vitro. However, these compounds did not show substantial potency in
vivo due to their poor stability [15].

%CV: Coefficient of Variation; IS: Internal Standard; LLOQ: Lower
Limit Of Quantification; MRM: Multiple Reaction Monitoring; AMP:
Aminoprophos-Methyl; JCC76: N-(3-(2,5-dimethylbenzyloxy)-4(methylmethylsulfonamido)phenyl)cyclohexanecaboxamide;
%RE:
Relative Error; RME: Relative Matrix Effect; QC: Quality Control; SD:
Standard Deviation

Recently, we have developed a class of tubulin inhibitors as
anti-cancer agents [16,17]. These compounds share the same core
scaffold and bind to a colchicine-binding domain on tubulin [16].
We performed T. brucei cell-growth inhibition assays with our
compounds, some of which exhibited very specific inhibitory effects on
T. brucei growth resulting in selectivity indices (IC50 inhibiting human
cancer cell growth/IC50 inhibiting T. brucei cell growth) of 5 or more.
Among these compounds, BMCL26 has been identified as a potential
drug candidate. BMCL26 exhibited activity against T. brucei cell
proliferation with an IC50 of 1.62 µM but inhibited mammalian cell
growth with an IC50 of 55.35 µM [18]. The selective index of BMCL26 is
approximately 34, and its IC50 (for inhibiting T. brucei proliferation) is
in the low micromolar range, which is obtainable in blood. The present
investigation addresses the critical need of developing a method to
accurately quantify BMCL26 concentrations in blood. Thus, in this
paper, we report the development and validation of a robust and highly
sensitive LC-MS/MS method for quantitating BMCL26 in rat plasma
with an LLOQ of 0.5 ng/mL and a linear calibration range of up to 100
ng/mL.

BMCL26;
precipitation; Rat plasma

Anti-parasitic;

LC-MS/MS;

Abbreviations

Introduction
Human African trypanosomiasis, also known as sleeping sickness,
is a vector-borne parasitic disease and a serious health threat to a large
number of people living in sub-Saharan Africa, where health systems
are challenged at best [1-3]. Trypanosoma brucei gambiense (T. b.
gambiense) and Trypanosoma brucei rhodesiense (T. b. rhodesiense)
are the etiological parasites that cause sleeping sickness in humans.
These parasites live and grow extracellularly in the blood and tissue
fluids of humans or cattle and are transmitted among hosts by tsetse
flies (Glossina spp.). Without effective treatment, the disease can lead
to coma and ultimately death. If the patients do not receive treatment
in a timely manner, the neurological damage caused by these parasites
is irreversible even after treatment [3,4]. Current drugs used to treat
human trypanosomiasis include Suramin, Pentamidine, Melarsoprol and
Eflornithine [5], however, these drugs do not effectively treat the disease,
maintaining an urgent need for new, more effective and less expensive
drugs for the treatment of human African trypanosomiasis [4-6].
Tubulin is a very attractive target in the field of anti-cancer drug
discovery, and several successful tubulin binders are used clinically
as first-line chemotherapeutic agents [7]. Tubulin also plays an
essential role during trypanosome cell division. The fast, populationdoubling rate of trypanosomes makes them highly dependent on
tubulin polymerization/depolymerization [8]. More importantly,
tubulin is critical for trypanosome locomotion, which is essential for
trypanosomes survival. Tubulin inhibitors not only block T. brucei
cell division but also affect the locomotive functions of flagellum and
lead to cell death [9]. Some microtubule-disrupting herbicides, such
as phosphoric thioamide herbicide Amiprophos-Methyl (APM) and
dinitroaniline herbicides, exhibit activity against protozoan parasites
by targeting tubulin [10-14]. Research works have optimized these
compounds, generating more potent and selective tubulin inhibitors for
J Anal Bioanal Tech
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Experimental
Chemicals and reagents
BMCL26 and JCC76 (internal standard) were synthesized and
purified according to previously published procedures [18,19].
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Methanol (HPLC grade) and acetonitrile were from Pharmco-Apper
(Philadelphia, Pennsylvania, USA). Formic acid and ammonium
acetate (analytical grade) were purchased from Sigma Aldrich
Chemical Company (Allentown, Pennsylvania, USA). Deionized water
was obtained using a Barnstead Nano pure water purification system
with a Nanopure Diamond Pack Organic free DI cartridge from
Thermo Scientific (Waltham, Massachusetts, USA). Six individual lots
of rat plasma (Sprague-Dawley rat plasmas K2) were obtained from
Innovative Research (Novi, Michigan, USA) (Figure 1).

was used for quantification, with the transitions set at m/z 573.3
→ 493.2 for BMCL26 and m/z 443.2 → 79.1 for JCC76 (IS) (Figure
2), respectively. The following ion-source-dependent parameters
were used: nebulization gas (30), heating gas (30), curtain gas (35),
ion spray voltage (-4330 ev) and temperature (500°C). Compounddependent parameters were manually optimized as follows:
declustering potential, -40; entrance potential, -10; collision energy
and cell exit potential for both analyte and internal standard, -30,
-100, -13, and -9.

Calibration standards and quality-control samples

(A)

Preparation of stock and working solutions: A set of BMCL26
working solutions containing 10, 20, 50, 150, 400, 1000 and 2000 ng/
mL were prepared by serial dilution using methanol and 1 mg/mL
stock solution. The 150 ng/mL working solution of JCC76 (IS) was
diluted from a stock solution of 1 mg/mL in methanol. Stock solutions
and working solutions were stored at -20°C and 4°C.

Calibration and preparation of quality-control (QC) plasma
samples
Calibration plasma samples were prepared by spiking 10 µl of
corresponding BMCL26 working solutions in 200 µl of rat plasma
(mixture of 6 lots) with drug concentrations of 0.5, 1.0, 2.5, 5, 12.5, 25,
50, and 100 ng/mL. QC samples at three concentrations, 1.25 (low),
10 (mid) and 80 (high) ng/mL, were prepared by adding 10 µL of the
appropriate BMCL26 working solution and 200 µL of drug-free plasma.
Calibration and QC samples were frozen at -20°C overnight and then
treated using the following sample preparation procedure before LCMS/MS analysis.

Sample extraction
QC samples and blanks were removed from the -20°C freezer and
thawed to room temperature. Ten µl of JCC76 working solution were
spiked into each 200 μL aliquot of plasma calibrators/QCs/blanks,
excepting the double blank, into which 10 µL of acetonitrile was added.
The solutions were then vortexed immediately for 30 sec, after which
each sample was deproteinized by adding 800 µl of 0.1% formic acid
in acetonitrile, sonicating for 15 minutes, and centrifuging at 13,000
× g for 15 minutes. The supernatants were then transferred into auto
sampler vials for LC-MS/MS analysis.

(B)

BMCL26

JCC76

Figure 1: The chemical structures of JCC76 (A), internal standard BMCL26 (B).
Minutes

Event

Parameters

B%

70 (isocratic)

0.6-1.6

B%

70-90 (liner)

0-3.5

Total flow

0.25 ml/min

3.5-3.7

Total flow

0.25-0.6 ml/min

1.6-5.5

B%

90 (isocratic)

5.5-5.6

B%

90-70 (liner)

3.5-5.9

Total flow

0.6 ml/min

5.9-6.0

Total flow

0.25-0.6 ml/min

B%

70 (liner)

0-0.6

5.6-7.5

Table 1: HPLC gradient program.

LC-MS/MS analysis
LC-MS/MS analysis was performed using a 5500 Q-TRAP triple
quadrupole, tandem mass spectrometer (AB Sciex, Toronto, Canada)
coupled with an Electrospray Ionizer (ESI) operated in negative ion
mode (Framingham, Massachusetts, USA) and interfaced with High
Performance Liquid Chromatography (HPLC, Shimadzu, Columbia,
Maryland, USA) system that uses auto-sampling and online vacuum
degassing. All data acquisition and processing were conducted using
Analyst software, version 1.5.2 (AB Sciex).
Analytical separation of BMCL26 was achieved using a Luna C8
(2) HPLC column (50 × 2.0 mm, 5 micron) with a C8 security-guard
cartridge from Phenomenex (Torrance, California, USA). Mobile
phase A contained 50 µM ammonium acetate in 2% Methanol,
and mobile phase B contained 50 µM ammonium acetate in 90%
Methanol. Sample aliquots of 5 µl were injected onto the column and
eluted via the following gradient flow: 0-0.6 min, 70% B, 1.6 min, 90%
B, 7.5 min, and stop (Table 1). The column was equilibrated for 0.5
min before each run. Negative electrospray ionization (ESI) mode
was selected, and the MRM (multiple reaction monitoring) function
J Anal Bioanal Tech
ISSN: 2155-9872 JABT, an open access journal

Figure 1: The chemical structures of JCC76 (A), internal standard BMCL26 (B).

Figure 2: Precursor/product ion spectra and proposed fragmentation pathways
for internal standard JCC76 (A) and analyte BMCL26 (B).
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Analytical method validation
The LC-MS/MS assay was fully validated according to the Food and
Drug Administration (FDA) Bioanalytical Method Guidelines [20] and
other references [21-23]. The entire assay was validated for linearity,
accuracy, precision, selectivity, extraction recovery, matrix effect and
stability.

Linearity and calibration
Eight concentrations of BMCL26 (0.5, 1.0, 2.5, 5, 12.5, 25, 50, and
100 ng/mL) were selected for the plasma calibration curve (n=2 for
each of the eight calibrators, average for each calibrator plotted). A
weighed linear regression, using 1/x as the weighing factor, was used to
calculate the slope and correlation coefficient of the calibration curve.

Accuracy and precision
To determine the intra- and inter-day accuracy and precision of the
assay, we tested five replicates of BMCL26 at the LQC, MQC, and HQC
using 1.25, 10 and 80 ng/mL. Intra-assay and inter-assay precisions
were defined as Relative Standard Deviations (RSD) between replicate
measurements. Accuracies were calculated using the following formula:
accuracy (%)=(experimental concentration - spiked concentration)/
(spiked concentration) × 100. The criteria for data acceptability
included accuracy and precisions within ± 15% of the nominal value
and the RSD.

Extraction recovery and matrix effects
The extraction recoveries and matrix effects of BMCL26 for three
concentrations of QC samples (low, 1.25 ng/mL; medium, 10 ng/
mL; and high, 80 ng/mL) were determined by comparing peak areas
of analyte-spiked plasma aliquots before extraction to peak areas of
analyte-spiked solutions extracted from blank plasma and comparing
the response of solutions spiked with analyte after extraction to the
response of analyte dissolved in the mobile phase.

It was found that analyte and IS solutions prepared in methanol-water
(9:1, v/v) yielded stronger signals compared to solutions prepared
in acetonitrile-water (9:1, v/v). Adding ammonium acetate to the
methanol-water solution substantially increased BMCL26 signals.
Therefore, a gradient flow of methanol-water-ammonium acetate was
chosen for the HPLC mobile phase. Figure 2 showed the parent ion
spectra for both BMCL26 and IS. The highest fragment-ion signals
were obtained by fine-tuning the collision energy, spray voltage, and
ion source temperature. Based on our ionization and fragmentation
optimization results, we chose MRM transitions of m/z 573.2 → 493.2
for BMCL26 and 443.2 → 79.1 for IS for quantification, as these product
ions yielded strong and stable signals.

Optimization of HPLC conditions
The gradient flow of the mobile phase, which was used with different
flow rates, was as follows: A: 50 µM ammonium acetate in 2% methanol
and mobile phase; B: 50 µM ammonium acetate in 90% methanol (Table
1). Because the C-18 column had a carry-over problem with BMCL26,
a C-8 column was used instead. The C-8 column effectively resolved the
carryover problem and also yielded a better peak shape. Thus, BMCL26
and IS were separated using a C-8 column with a flow rate of 0.25 mL/
min for 3.5 min, after which the flow rate was increased to 0.6 mL/
min for column clean up and re-equilibration. Retention times were
observed at 2.51 min for BMCL26 and 3.14 min for IS (Figure 3). The
total run time was 8 min.

Linearity, sensitivity, selectivity and LLOQ
Using the concentrations of BMCL26 in the working solutions,
plasma calibration curves were constructed over a concentration range

Stability studies
The stabilities of BMCL26 in rat plasma samples were determined
using two distinct QC standards (1.25 and 80 ng/mL), which were
tested after 8 hours at room temperature and after two months at -20°C;
freeze-thaw stabilities were determined using three freeze-thaw cycles
over a three day period. Short-term stabilities were also determined
for post-preparation QC standards stored at room temperature for
10 hours. The QC results obtained after storage were compared with
spiked concentration values by determining the percentage ratios of
experimental values divided by spiked values.
The stabilities of stock and working solutions for both analyte
and internal standard were also evaluated. Stock solutions of analyte
and IS were stored at -20°C for 9 months. From both stored and fresh
stock solutions, two QC standards (1.25 and 80 ng/mL) were prepared
for the analyte, to which 7.5 ng/mL IS (JCC76) was added, and the
experimentally determined concentrations of BMCL26 and JCC76
were compared (n=3 for each).

Results and Discussion
Optimization
quantitation

of

mass

spectrometric

conditions

for

The negative ionization mode was selected for both BMCL26 and
JCC76 (IS) detection in this study because the analyte produced a much
stronger signal for negative ionization compared to positive ionization.
J Anal Bioanal Tech
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Figure 3: (A) MRM chromatograms of blank rat plasma in both IS and Analyte
windows (B) IS JCC76 (10 ng/ml, 3.12 min) and BMCL26 at LLOQ level (0.5
ng/ml, 2.48 min).
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Extraction recovery and matrix effects

of 0.5-100 ng/mL. Linearity results showed a quadratic fit for BMCL26
using an eight-point calibration curve (0.5, 1, 2.5, 5, 12.5, 25, 50, and 100
ng/mL) with JCC76 (7.5 ng/mL) as the internal standard in the plasma
samples. Excellent linearity was obtained with a correlation coefficient
(r2) of 0.9993. The linear regression equation was y=0.073x-0.0085. This
method exhibited high selectivity and displayed no interfering peaks in
six different blank plasma samples from different sources. Using the
calibration curve, the LLOQ of the method was determined to be 0.5
ng/mL. The accuracy and precision were determined for each lot of
plasma at the LLOQ. The data were summarized in Table 2.

It was found that protein precipitation was a good way to
extract BMCL26 from plasma. Initially, we used 80% acetonitrile to
precipitate plasma proteins, but a strong matrix effect was observed.
Consequently, we utilized pure acetonitrile to precipitate proteins
with 0.1% formic acid (for deproteinization). The latter precipitation
conditions eliminated the matrix effect and achieved symmetrical
chromatographic peak shapes. The absolute and relative extraction
recoveries were in the range of 90.16-105.00%. The results were
summarized in Table 4. As shown in Table 5, the absolute and relative
matrix effects of BMCL26 from six different rat plasma samples at three
QC concentrations (low (1.25 ng/mL), medium (10 ng/mL), and high
(80 ng/mL) ranged from 101.30-110.10%.

Accuracy and precision
Intra- and inter-assay accuracies (%RE) and precisions (%CV)
were evaluated by analyzing five replicates of low, medium, and high
QC standards. As summarized in Table 3, the assay’s intra- and interday relative errors were 0.62 and 11.36%, respectively, and the assay’s
intra- and inter-day precisions were 0.84-3.47%, respectively. These
values were within acceptable limits according to FDA guidelines.

Stability
The stability of BMCL26 was determined by comparing the mean
peak area ratios of BMCL26 to IS in low (1.25 ng/mL) and high (80 ng/

Nominal Concentration (ng/mL)

Determined Concentration (ng/mL)

Accuracy (%RE)

Precision (%CV)

0.5

0.47 ± 0.03

-7.46

5.59

1

0.99 ± 0.02

-0.22

2.09

2.5

2.54 ± 0.05

1.40

2.01

5

5.14 ± 0.27

2.80

5.24

12.5

12.75 ± 0.31

2.00

2.41

25

25.27 ± 0.73

1.08

2.90

50

51.03 ± 0.97

2.06

1.90

100

98.26 ± 0.99

-1.74

1.01

Table 2: Accuracy and precision of BMCL26 calibration standards in rat plasma (n=5, pooled plasma samples).
Intra-assay

Inter-assay

Normal (ng/ml)

Determined (ng/ml)

Accuracy (%RE)

Accuracy (%RE)

SD

Precision (%CV)

1.25

1.20

11.36

0.02

1.72

1.36

9.12

0.04

3.38

10

10.20

2.00

0.16

1.64

10.20

2.00

0.35

3.43

80

80.70

0.87

0.68

0.84

80.50

0.62

2.80

3.47

SD

Precision (%CV)

Determined (ng/ml)

Table 3: Inter and intra-assay accuracy and precision of BMCL26 in rat plasma.
Concentration of QC samples(ng/ml)

Absolute

Relative

Mean extraction recovery

%CV

Mean extraction recovery

%CV

1.25

104.00 ± 4.89

4.70

98.10 ± 9.73

9.92

10

105.00 ± 4.99

4.75

95.96 ± 3.61

3.76

80

96.30 ± 3.00

3.12

90.16 ± 2.87

3.18

Table 4: Absolute and relative Extraction recovery of BMCL26 in rat plasma.
Concentration of QC samples(ng/ml)

Absolute

Relative

Mean matrix effect

%CV

Mean matrix effect

%CV

1.25

105.00 ± 1.07

1.02

108.00 ± 5.15

4.77

10

107.00 ± 6.06

5.66

110.10 ± 8.99

8.17

80

105.00 ± 3.86

3.68

101.30 ± 4.78

4.72

Table 5: Absolute and relative matrix effect of BMCL26 in rat plasma.
Storage conditions

Concentration (ng/ml)

Recovery %

Bench top (8 hr)

1.25

103.46

At room temp

80.00

103.20

1.25

98.13

80.00

105.20

Post extraction

1.25

101.86

(10 hr) at room temp

80.00

107.54

Freeze thaw (3 cycles)

Table 6: Stability of BMCL26 in plasma samples.
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mL) QC samples to those of freshly prepared QC solutions (containing
the same concentrations), expressed in terms of recovery. As shown in
Table 6, the receives of LQC and HQC samples were 103.46-103.20%,
98.13-105.20%, and 101.86-107.54% for bench top conditions, after
3 freeze-thaw cycles and post extraction at room temperature for 10
hours, respectively. The stabilities of working solutions of BMCL26
and internal standard (JCC76), stored at 4°C for at least 6 months,
were determined to be 99.60-105.00% and 115.60% for the two
QC standards tested (1.25 and 80 ng/mL), to which 7.5 ng/mL IS
was added (using the stored stock solution). These stability results
showed no significant deviations in BMCL26 quantification under the
experimental conditions used.

Conclusion
This innovative method offers several advantages for assaying
BMCL26 in rat plasma including simplicity, cost effectiveness,
accuracy and precision were below 11% and 3%, with high sensitivity
and selectivity. To our knowledge, this is the first time this method was
used. This assay employed a simple protein precipitation procedure for
plasma sample preparation. The LLOQ was as low as 0.5 ng/mL. The
results from the validation study illustrated that this method can be
used to determine the pharmacological and toxicological profiles of
BMCL26 in rats in the future.
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